Recent Advances in Melanoma
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 42
Special Issue Editors
Interests: dermatopathology; skin pigmentation; neuroendocrinology of the skin; photobiology; melanoma; steroidogenesis; vitamin D; sterols; melatonin; stress response mechanisms
Special Issues, Collections and Topics in MDPI journals
Interests: dermatoendocrinology; melanoma; melanogenesis; photobiology; cutaneous cells; mitochondria; oxidative stress; melatonin and its metabolites
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Melanoma represents the most rapidly increasing malignancy with a high mortality rate. Despite groundbreaking new treatments, e.g., combination of anti-PD-1 and anti-CTLA-4 immunotherapy or targeted therapy (inhibition of BRAF/MEK kinases), the overall responses rates in patients with metastatic melanoma reach the level of 58% and 78%, respectively. Thus, new agents with additional anti-tumour capacities are highly desired. To date, studies looking at the outcomes from the advancement of anti-melanoma drugs have described that pre-operative therapy can extend survival rates after surgery. Nonetheless, no selective therapeutic options have been accepted as the basal adjuvant or neoadjuvant background for drug-resistant melanoma, and a substantial number of melanoma patients have died; therefore, unmet medical needs have consistently increased. As a result, anti-melanoma drug resistance remains a fundamental challenge in the treatment of patients with advance melanoma.
The goal of enclosed Special Issue is to collect the latest findings on a broad range of research including basic research in vitro, preclinical models involving substances potentially used as breakthrough clinical solutions for drug-resistant tumours as well as the newly introduced compounds targeting melanoma therapy. We welcome original experimental research, review articles, and commentary articles describing different aspects of this devastating disease. Articles on melanoma diagnosis and on mechanisms underlying melanomagenesis and melanoma progression are also invited.
Prof. Dr. Andrzej Slominski
Dr. Konrad Kleszczyński
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- melanoma
- anti-cancer
- immunotherapy
- targeted therapy
- signaling pathway
- pharmacotherapy
- biomarkers
- clinical outcome
- combination immunotherapy
- mitochondria
- dermatoendocrinology
- skin therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
